Related Experiment Video
Updated: Sep 21, 2025

Author Spotlight: Illuminating New Avenues for Adipose Tissue Metabolism and Disease Prevention
Published on: October 6, 2023
Thrombosis origin identification of cardioembolism and large artery atherosclerosis by distinct metabolites
Wei Li1,2,3, Xuesong Bai1,3, Jiheng Hao2
1Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
Insights
Six distinct metabolites can now differentiate between cardioembolic and large artery atherosclerosis cerebral thrombosis. This finding aids in understanding stroke causes and preventing future events.
Area of Science:
- Biochemistry
- Neurology
- Medical Diagnostics
Background:
- Diagnosing the origin of cerebral thrombosis is challenging.
- Distinguishing between cardioembolism (CE) and large artery atherosclerosis (LAA) is crucial for effective treatment.
- Metabolomic profiling offers a novel approach to identify distinct biomarkers.
Purpose of the Study:
- To identify distinct metabolites differentiating CE and LAA cerebral thrombi.
- To develop a predictive model for classifying thrombosis origins using identified metabolites.
- To enhance understanding of the pathogenesis of different stroke types.
Main Methods:
- Ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) was used to analyze thrombi metabolites.
- Machine learning classifiers, including random forest (RF), were employed to build and evaluate predictive models.
- Metabolite data from 26 CE and 22 LAA thrombi were analyzed.
Main Results:
- Significant differences in metabolite levels and enriched metabolic pathways were observed between CE and LAA thrombi.
- Six key metabolites were identified as potential predictors for distinguishing thrombosis origins.
- A random forest model demonstrated high predictive accuracy (AUC=0.889) for classifying thrombosis types.
Conclusions:
- Six specific metabolites serve as reliable predictors for differentiating cerebral thrombi of CE and LAA origin.
- These findings contribute to a better understanding of stroke pathogenesis.
- The identified biomarkers are valuable for secondary stroke prevention strategies.
Background:
The diagnosis of cerebral thrombosis origin is challenging and remains unclear. This study aims to identify thrombosis due to cardioembolism (CE) and large artery atherosclerosis (LAA) from a new perspective of distinct metabolites.
Methods:
Distinct metabolites between 26 CE and 22 LAA origin thrombi, which were extracted after successful mechanical thrombectomy in patients with acute ischemic stroke in the anterior circulation, were analyzed with a ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) system. Enriched metabolic pathways related to the metabolites were identified. Least absolute shrinkage selection operator regression analyses and a filtering method were used to select potential predictors. Furthermore, four machine learning classifiers, including decision tree, logistic regression, random forest (RF), and k means unsupervised classification model, were used to evaluate the predictive ability of the selected metabolites.
Results:
UPLC-QTOF-MS analysis revealed that levels of 88 and 55 metabolites were elevated in LAA and CE thrombi, respectively. Kyoto Encyclopedia of Genes and Genomes analysis revealed a significant difference between the pathways enriched in the two types of thrombi. Six metabolites (diglyceride (DG, 18:3/24:0), DG (22:0/24:0), phytosphingosine, galabiosylceramide (18:1/24:1), triglyceride (15:0/16:1/o-18:0), and glucosylceramide (18:1/24:0)) were finally selected to build a predictive model. The predictive RF model was confirmed to be the best, with a satisfactory stability and prediction capacity (area under the curve=0.889).
Conclusions:
Six metabolites as potential predictors for distinguishing between cerebral thrombi of CE and LAA origin were identified. The results are useful for understanding the pathogenesis and for secondary stroke prevention.
More Related Videos
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
13:10Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Published on: September 25, 2016
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis I: Introduction
Venous Thrombosis I: Introduction
Imaging Studies for Cardiovascular System V: CT